Real-time enrollment status for this recurrent multiple myeloma clinical trial
Current Status
Recruiting
Checked: September 4, 2026 at 11:55 PM UTC
| NCT Number | NCT06785415 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 37 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | June 25, 2026 (Jun 25, 2026) |
As of September 4, 2026: Clinical trial NCT06785415 is currently recruiting participants. This phase1 study for recurrent multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06785415 is actively recruiting participants as of September 4, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06785415 was last updated Jun 25, 2026 (June 25, 2026). HelloStudys verifies this status automatically.